Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
9
×
national blog main
san francisco blog main
9
×
life sciences
national top stories
boston blog main
boston top stories
raleigh-durham blog main
san francisco top stories
startups
deals
fda
investing
new york blog main
san diego blog main
seattle blog main
clinical trials
detroit blog main
detroit top stories
indiana blog main
raleigh-durham top stories
san diego top stories
seattle top stories
software
venture capital
wisconsin blog main
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
glaxosmithkline
indiana top stories
ipo
medical device
medical devices
medicare
messenger rna
national
new york top stories
What
million
9
×
therapeutics
new
startup
cancer
drug
medical
raised
closed
help
ipo
patients
pipeline
round
sciences
week
year
adding
adds
alliance
allogene
analytics
ann
arbor
areas
athena
auris
based
beta
bets
bio
biofourmis
bionics
biosciences
biotech
biotechs
bio’s
blood
boost
brii
Language
unset
Current search:
million
×
" san francisco blog main "
×
biotech
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
6 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round